메뉴 건너뛰기




Volumn 36, Issue 9, 2015, Pages 605-616

Novel therapeutics in myocardial infarction: Targeting microvascular dysfunction and reperfusion injury

Author keywords

coronary microcirculation; myocardial infarction; novel therapeutics; reperfusion injury

Indexed keywords

ADENOSINE; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR AGENT; CYCLOSPORIN; DELCASERTIB; ELAMIPRETIDE; ERYTHROPOIETIN; EXENDIN 4; FX 06; GLUCOSE; IK 5001; INSULIN; LOSMAPIMOD; METFORMIN; NICORANDIL; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PEXELIZUMAB; PIOGLITAZONE; PLACEBO; POTASSIUM; TRO 40303; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

EID: 84941314655     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.06.004     Document Type: Review
Times cited : (54)

References (137)
  • 1
    • 84893651437 scopus 로고    scopus 로고
    • Heart disease and stroke statistics - 2014 update: A report from the American Heart Association
    • A.S. Go, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
    • (2014) Circulation , vol.129 , pp. e28-e292
    • Go, A.S.1
  • 2
    • 33644878249 scopus 로고    scopus 로고
    • Cardiovascular disease in the developing world and its cost-effective management
    • T.A. Gaziano Cardiovascular disease in the developing world and its cost-effective management Circulation 112 2005 3547 3553
    • (2005) Circulation , vol.112 , pp. 3547-3553
    • Gaziano, T.A.1
  • 3
    • 84855718052 scopus 로고    scopus 로고
    • A tale of coronary artery disease and myocardial infarction
    • E.G. Nabel, and E. Braunwald A tale of coronary artery disease and myocardial infarction N. Engl. J. Med. 366 2012 54 63
    • (2012) N. Engl. J. Med. , vol.366 , pp. 54-63
    • Nabel, E.G.1    Braunwald, E.2
  • 4
    • 34247854930 scopus 로고    scopus 로고
    • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006
    • K.A. Fox, and et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
    • (2007) JAMA , vol.297 , pp. 1892-1900
    • Fox, K.A.1
  • 5
    • 84902163265 scopus 로고    scopus 로고
    • Reperfusion strategies in acute coronary syndromes
    • A. Bagai, and et al. Reperfusion strategies in acute coronary syndromes Circ. Res. 114 2014 1918 1928
    • (2014) Circ. Res. , vol.114 , pp. 1918-1928
    • Bagai, A.1
  • 6
    • 84871311607 scopus 로고    scopus 로고
    • 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease
    • A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
    • S.D. Fihn, and et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol. 60 2012 e44 e164
    • (2012) J. Am. Coll. Cardiol. , vol.60 , pp. e44-e164
    • Fihn, S.D.1
  • 7
    • 10044243901 scopus 로고    scopus 로고
    • Reperfusion treatment of ST-elevation acute myocardial infarction
    • F. Ribichini, and et al. Reperfusion treatment of ST-elevation acute myocardial infarction Prog. Cardiovasc. Dis. 47 2004 131 157
    • (2004) Prog. Cardiovasc. Dis. , vol.47 , pp. 131-157
    • Ribichini, F.1
  • 8
    • 0037426087 scopus 로고    scopus 로고
    • Acute myocardial infarction
    • E. Boersma, and et al. Acute myocardial infarction Lancet 361 2003 847 858
    • (2003) Lancet , vol.361 , pp. 847-858
    • Boersma, E.1
  • 9
    • 67650169237 scopus 로고    scopus 로고
    • Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: National cohort study
    • S.S. Rathore, and et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study BMJ 338 2009 b1807
    • (2009) BMJ , vol.338 , pp. b1807
    • Rathore, S.S.1
  • 10
    • 77952550270 scopus 로고    scopus 로고
    • Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data
    • K.A. Fox, and et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data J. Am. Coll. Cardiol. 55 2010 2435 2445
    • (2010) J. Am. Coll. Cardiol. , vol.55 , pp. 2435-2445
    • Fox, K.A.1
  • 11
    • 84872698656 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • American College of Emergency Physicians, and et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 61 2013 e78 e140
    • (2013) J. Am. Coll. Cardiol. , vol.61 , pp. e78-e140
    • American College of Emergency Physicians1
  • 12
    • 0037417523 scopus 로고    scopus 로고
    • Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
    • E.C. Keeley, and et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
    • (2003) Lancet , vol.361 , pp. 13-20
    • Keeley, E.C.1
  • 13
    • 49649090926 scopus 로고    scopus 로고
    • Angioplasty strategies in ST-segment-elevation myocardial infarction: Part I: Primary percutaneous coronary intervention
    • G.W. Stone Angioplasty strategies in ST-segment-elevation myocardial infarction: part I: primary percutaneous coronary intervention Circulation 118 2008 538 551
    • (2008) Circulation , vol.118 , pp. 538-551
    • Stone, G.W.1
  • 14
    • 0029892528 scopus 로고    scopus 로고
    • Time from symptom onset to treatment and outcomes after thrombolytic therapy
    • L.K. Newby, and et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy J. Am. Coll. Cardiol. 27 1996 1646 1655
    • (1996) J. Am. Coll. Cardiol. , vol.27 , pp. 1646-1655
    • Newby, L.K.1
  • 15
    • 0034647275 scopus 로고    scopus 로고
    • Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
    • C.P. Cannon, and et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
    • (2000) JAMA , vol.283 , pp. 2941-2947
    • Cannon, C.P.1
  • 16
    • 0041733921 scopus 로고    scopus 로고
    • Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty
    • G. De Luca, and et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty J. Am. Coll. Cardiol. 42 2003 991 997
    • (2003) J. Am. Coll. Cardiol. , vol.42 , pp. 991-997
    • De Luca, G.1
  • 17
    • 0017643309 scopus 로고
    • The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs
    • K.A. Reimer, and et al. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
    • (1977) Circulation , vol.56 , pp. 786-794
    • Reimer, K.A.1
  • 18
    • 85047680870 scopus 로고
    • Myocardial reperfusion in the pig heart model: Infarct size and duration of coronary occlusion
    • D. Garcia-Dorado, and et al. Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion Cardiovasc. Res. 21 1987 537 544
    • (1987) Cardiovasc. Res. , vol.21 , pp. 537-544
    • Garcia-Dorado, D.1
  • 19
  • 20
    • 84873848690 scopus 로고    scopus 로고
    • Myocardial ischemia-reperfusion injury: A neglected therapeutic target
    • D.J. Hausenloy, and D.M. Yellon Myocardial ischemia-reperfusion injury: a neglected therapeutic target J. Clin. Invest. 123 2013 92 100
    • (2013) J. Clin. Invest. , vol.123 , pp. 92-100
    • Hausenloy, D.J.1    Yellon, D.M.2
  • 21
    • 0032076528 scopus 로고    scopus 로고
    • A fresh look at reperfusion injury
    • H.M. Piper, and et al. A fresh look at reperfusion injury Cardiovasc. Res. 38 1998 291 300
    • (1998) Cardiovasc. Res. , vol.38 , pp. 291-300
    • Piper, H.M.1
  • 22
    • 0020414455 scopus 로고
    • The stunned myocardium: Prolonged, postischemic ventricular dysfunction
    • E. Braunwald, and R.A. Kloner The stunned myocardium: prolonged, postischemic ventricular dysfunction Circulation 66 1982 1146 1149
    • (1982) Circulation , vol.66 , pp. 1146-1149
    • Braunwald, E.1    Kloner, R.A.2
  • 23
    • 0021591285 scopus 로고
    • Reperfusion-induced arrhythmias: Mechanisms and prevention
    • A.S. Manning, and D.J. Hearse Reperfusion-induced arrhythmias: mechanisms and prevention J. Mol. Cell. Cardiol. 16 1984 497 518
    • (1984) J. Mol. Cell. Cardiol. , vol.16 , pp. 497-518
    • Manning, A.S.1    Hearse, D.J.2
  • 24
    • 33847231568 scopus 로고    scopus 로고
    • Coronary microvascular dysfunction
    • P.G. Camici, and F. Crea Coronary microvascular dysfunction N. Engl. J. Med. 356 2007 830 840
    • (2007) N. Engl. J. Med. , vol.356 , pp. 830-840
    • Camici, P.G.1    Crea, F.2
  • 25
    • 33747874714 scopus 로고    scopus 로고
    • No-reflow phenomenon and prognosis in patients with acute myocardial infarction
    • H. Ito No-reflow phenomenon and prognosis in patients with acute myocardial infarction Nat. Clin. Pract. Cardiovasc. Med. 3 2006 499 506
    • (2006) Nat. Clin. Pract. Cardiovasc. Med. , vol.3 , pp. 499-506
    • Ito, H.1
  • 26
    • 28144436807 scopus 로고    scopus 로고
    • Management of microvascular dysfunction and reperfusion injury
    • A. Prasad, and B.J. Gersh Management of microvascular dysfunction and reperfusion injury Heart 91 2005 1530 1532
    • (2005) Heart , vol.91 , pp. 1530-1532
    • Prasad, A.1    Gersh, B.J.2
  • 27
    • 73449098557 scopus 로고    scopus 로고
    • Reperfusion injury, microvascular dysfunction, and cardioprotection, the "dark side" of reperfusion
    • A. Prasad, and et al. Reperfusion injury, microvascular dysfunction, and cardioprotection, the "dark side" of reperfusion Circulation 120 2009 2105 2112
    • (2009) Circulation , vol.120 , pp. 2105-2112
    • Prasad, A.1
  • 28
    • 84924175586 scopus 로고    scopus 로고
    • ESC working group cellular biology of the heart: Position paper: Improving the preclinical assessment of novel cardioprotective therapies
    • S. Lecour, and et al. ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies Cardiovasc. Res. 104 2014 399 411
    • (2014) Cardiovasc. Res. , vol.104 , pp. 399-411
    • Lecour, S.1
  • 29
    • 84922668835 scopus 로고    scopus 로고
    • Remote ischemic conditioning
    • G. Heusch, and et al. Remote ischemic conditioning J. Am. Coll. Cardiol. 65 2015 177 195
    • (2015) J. Am. Coll. Cardiol. , vol.65 , pp. 177-195
    • Heusch, G.1
  • 30
    • 33845981823 scopus 로고    scopus 로고
    • Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial
    • P.W. Armstrong, and et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial JAMA 297 2007 43 51
    • (2007) JAMA , vol.297 , pp. 43-51
    • Armstrong, P.W.1
  • 31
    • 84907396129 scopus 로고    scopus 로고
    • Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: Results of the PROTECTION AMI Randomized Controlled Trial
    • A.M. Lincoff, and et al. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial Eur. Heart J. 35 2014 2516 2523
    • (2014) Eur. Heart J. , vol.35 , pp. 2516-2523
    • Lincoff, A.M.1
  • 32
    • 77949337131 scopus 로고    scopus 로고
    • Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The STATIN STEMI trial
    • J-S. Kim, and et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial JACC Cardiovasc. Interv. 3 2010 332 339
    • (2010) JACC Cardiovasc. Interv. , vol.3 , pp. 332-339
    • Kim, J.-S.1
  • 33
    • 82555189918 scopus 로고    scopus 로고
    • Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
    • J-Y. Hahn, and et al. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am. Heart J. 162 2011 1026 1033
    • (2011) Am. Heart J. , vol.162 , pp. 1026-1033
    • Hahn, J.-Y.1
  • 34
    • 84867900547 scopus 로고    scopus 로고
    • Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial
    • S. Post, and et al. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheter. Cardiovasc. Interv. 80 2012 756 765
    • (2012) Catheter. Cardiovasc. Interv. , vol.80 , pp. 756-765
    • Post, S.1
  • 35
    • 77958518157 scopus 로고    scopus 로고
    • A single dose of erythropoietin in ST-elevation myocardial infarction
    • A.A. Voors, and et al. A single dose of erythropoietin in ST-elevation myocardial infarction Eur. Heart J. 31 2010 2593 2600
    • (2010) Eur. Heart J. , vol.31 , pp. 2593-2600
    • Voors, A.A.1
  • 36
    • 78349287458 scopus 로고    scopus 로고
    • Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention a randomized, double-blind trial
    • I. Ott, and et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention a randomized, double-blind trial Circ. Cardiovasc. Interv. 3 2010 408 413
    • (2010) Circ. Cardiovasc. Interv. , vol.3 , pp. 408-413
    • Ott, I.1
  • 37
    • 80052666905 scopus 로고    scopus 로고
    • Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: A randomised controlled clinical trial
    • A.J. Ludman, and et al. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial Heart 97 2011 1560 1565
    • (2011) Heart , vol.97 , pp. 1560-1565
    • Ludman, A.J.1
  • 38
    • 84860771658 scopus 로고    scopus 로고
    • Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: The IMMEDIATE randomized controlled trial
    • H.P. Selker, and et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial JAMA 307 2012 1925 1933
    • (2012) JAMA , vol.307 , pp. 1925-1933
    • Selker, H.P.1
  • 39
    • 12544259347 scopus 로고    scopus 로고
    • Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial
    • S.R. Mehta, and et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
    • (2005) JAMA , vol.293 , pp. 437-446
    • Mehta, S.R.1
  • 40
    • 80052554958 scopus 로고    scopus 로고
    • New horizons in cardioprotection recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop
    • L.S. Longacre, and et al. New horizons in cardioprotection recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop Circulation 124 2011 1172 1179
    • (2011) Circulation , vol.124 , pp. 1172-1179
    • Longacre, L.S.1
  • 41
    • 84875170063 scopus 로고    scopus 로고
    • Translating cardioprotection for patient benefit: Position paper from the Working G-roup of Cellular Biology of the Heart of the European Society of Cardiology
    • D.J. Hausenloy, and et al. Translating cardioprotection for patient benefit: position paper from the Working G-roup of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc. Res. 98 2013 7 27
    • (2013) Cardiovasc. Res. , vol.98 , pp. 7-27
    • Hausenloy, D.J.1
  • 42
    • 77954789419 scopus 로고    scopus 로고
    • Postconditioning and protection from reperfusion injury: Where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
    • M. Ovize, and et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovasc. Res. 87 2010 406 423
    • (2010) Cardiovasc. Res. , vol.87 , pp. 406-423
    • Ovize, M.1
  • 43
    • 80053321770 scopus 로고    scopus 로고
    • Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study
    • G. Patti, and et al. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study J. Am. Coll. Cardiol. 58 2011 1592 1599
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. 1592-1599
    • Patti, G.1
  • 44
    • 84878317288 scopus 로고    scopus 로고
    • Platelet P2Y(1)(2) blockers confer direct postconditioning-like protection in reperfused rabbit hearts
    • X.M. Yang, and et al. Platelet P2Y(1)(2) blockers confer direct postconditioning-like protection in reperfused rabbit hearts J. Cardiovasc. Pharmacol. Ther. 18 2013 251 262
    • (2013) J. Cardiovasc. Pharmacol. Ther. , vol.18 , pp. 251-262
    • Yang, X.M.1
  • 45
    • 80051537724 scopus 로고    scopus 로고
    • Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): A paradigm shift in studies of infarct size limitation
    • D.J. Lefer, and R. Bolli Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): a paradigm shift in studies of infarct size limitation J. Cardiovasc. Pharmacol. Ther. 16 2011 332 339
    • (2011) J. Cardiovasc. Pharmacol. Ther. , vol.16 , pp. 332-339
    • Lefer, D.J.1    Bolli, R.2
  • 46
    • 84928014780 scopus 로고    scopus 로고
    • Plasma exosomes protect the myocardium from ischemia-reperfusion injury
    • J.M. Vicencio, and et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury J. Am. Coll. Cardiol. 65 2015 1525 1536
    • (2015) J. Am. Coll. Cardiol. , vol.65 , pp. 1525-1536
    • Vicencio, J.M.1
  • 47
    • 0037073890 scopus 로고    scopus 로고
    • Heart regeneration in zebrafish
    • K.D. Poss, and et al. Heart regeneration in zebrafish Science 298 2002 2188 2190
    • (2002) Science , vol.298 , pp. 2188-2190
    • Poss, K.D.1
  • 48
    • 0029887414 scopus 로고    scopus 로고
    • Innate protection of baboon myocardium: Effects of coronary artery occlusion and reperfusion
    • Y.T. Shen, and et al. Innate protection of baboon myocardium: effects of coronary artery occlusion and reperfusion Am. J. Physiol. 270 1996 H1812 H1818
    • (1996) Am. J. Physiol. , vol.270 , pp. H1812-H1818
    • Shen, Y.T.1
  • 49
    • 76749113471 scopus 로고    scopus 로고
    • Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - Implications for assessment of myocardial salvage
    • E. Hedstrom, and et al. Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage J. Cardiovasc. Magn. Reson. 11 2009 38
    • (2009) J. Cardiovasc. Magn. Reson. , vol.11 , pp. 38
    • Hedstrom, E.1
  • 50
    • 84911917373 scopus 로고    scopus 로고
    • Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning
    • P. Ferdinandy, and et al. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning Pharmacol. Rev. 66 2014 1142 1174
    • (2014) Pharmacol. Rev. , vol.66 , pp. 1142-1174
    • Ferdinandy, P.1
  • 51
    • 13944271065 scopus 로고    scopus 로고
    • Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future?
    • B.J. Gersh, and et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293 2005 979 986
    • (2005) JAMA , vol.293 , pp. 979-986
    • Gersh, B.J.1
  • 52
    • 0033809487 scopus 로고    scopus 로고
    • Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
    • I. Morishima, and et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction J. Am. Coll. Cardiol. 36 2000 1202 1209
    • (2000) J. Am. Coll. Cardiol. , vol.36 , pp. 1202-1209
    • Morishima, I.1
  • 53
    • 20244374697 scopus 로고    scopus 로고
    • Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction
    • P. Sorajja, and et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur. Heart J. 26 2005 667 674
    • (2005) Eur. Heart J. , vol.26 , pp. 667-674
    • Sorajja, P.1
  • 54
    • 1542409911 scopus 로고    scopus 로고
    • Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction
    • L. Bolognese, and et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction Circulation 109 2004 1121 1126
    • (2004) Circulation , vol.109 , pp. 1121-1126
    • Bolognese, L.1
  • 55
    • 0032478098 scopus 로고    scopus 로고
    • Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction
    • K.C. Wu, and et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
    • (1998) Circulation , vol.97 , pp. 765-772
    • Wu, K.C.1
  • 56
    • 0030034531 scopus 로고    scopus 로고
    • Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction
    • H. Ito, and et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction Circulation 93 1996 223 228
    • (1996) Circulation , vol.93 , pp. 223-228
    • Ito, H.1
  • 57
    • 16244422329 scopus 로고    scopus 로고
    • Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging
    • V. Hombach, and et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur. Heart J. 26 2005 549 557
    • (2005) Eur. Heart J. , vol.26 , pp. 549-557
    • Hombach, V.1
  • 58
    • 38949197815 scopus 로고    scopus 로고
    • Thrombus aspiration during primary percutaneous coronary intervention
    • T. Svilaas, and et al. Thrombus aspiration during primary percutaneous coronary intervention N. Engl. J. Med. 358 2008 557 567
    • (2008) N. Engl. J. Med. , vol.358 , pp. 557-567
    • Svilaas, T.1
  • 59
    • 44649157131 scopus 로고    scopus 로고
    • Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): A 1-year follow-up study
    • P.J. Vlaar, and et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study Lancet 371 2008 1915 1920
    • (2008) Lancet , vol.371 , pp. 1915-1920
    • Vlaar, P.J.1
  • 60
    • 84860471836 scopus 로고    scopus 로고
    • Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: The INFUSE-AMI randomized trial
    • G.W. Stone, and et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial JAMA 307 2012 1817 1826
    • (2012) JAMA , vol.307 , pp. 1817-1826
    • Stone, G.W.1
  • 61
    • 84886258945 scopus 로고    scopus 로고
    • Thrombus aspiration during ST-segment elevation myocardial infarction
    • O. Fröbert, and et al. Thrombus aspiration during ST-segment elevation myocardial infarction N. Engl. J. Med. 369 2013 1587 1597
    • (2013) N. Engl. J. Med. , vol.369 , pp. 1587-1597
    • Fröbert, O.1
  • 62
    • 84927144730 scopus 로고    scopus 로고
    • Randomized trial of primary PCI with or without routine manual thrombectomy
    • S.S. Jolly, and et al. Randomized trial of primary PCI with or without routine manual thrombectomy N. Engl. J. Med. 372 2015 1389 1398
    • (2015) N. Engl. J. Med. , vol.372 , pp. 1389-1398
    • Jolly, S.S.1
  • 63
    • 84868204030 scopus 로고    scopus 로고
    • Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: The MASTER Trial
    • G.W. Stone, and et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: the MASTER Trial J. Am. Coll. Cardiol. 60 2012 1975 1984
    • (2012) J. Am. Coll. Cardiol. , vol.60 , pp. 1975-1984
    • Stone, G.W.1
  • 64
    • 84901044979 scopus 로고    scopus 로고
    • A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)
    • D. Carrick, and et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI) J. Am. Coll. Cardiol. 63 2014 2088 2098
    • (2014) J. Am. Coll. Cardiol. , vol.63 , pp. 2088-2098
    • Carrick, D.1
  • 65
    • 84916608529 scopus 로고    scopus 로고
    • Pharmacologic therapy for reducing myocardial infarct size in clinical trials: Failed and promising approaches
    • S. Sattur, and et al. Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches J. Cardiovasc. Pharmacol. Ther. 20 2014 21 35
    • (2014) J. Cardiovasc. Pharmacol. Ther. , vol.20 , pp. 21-35
    • Sattur, S.1
  • 66
    • 0033995846 scopus 로고    scopus 로고
    • Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury
    • J. Buras Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury Int. Anesthesiol. Clin. 38 2000 91 109
    • (2000) Int. Anesthesiol. Clin. , vol.38 , pp. 91-109
    • Buras, J.1
  • 67
    • 0037028644 scopus 로고    scopus 로고
    • Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. Results of a pilot study utilizing intracoronary aqueous oxygen therapy
    • S.R. Dixon, and et al. Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. Results of a pilot study utilizing intracoronary aqueous oxygen therapy J. Am. Coll. Cardiol. 39 2002 387 392
    • (2002) J. Am. Coll. Cardiol. , vol.39 , pp. 387-392
    • Dixon, S.R.1
  • 68
    • 34447631860 scopus 로고    scopus 로고
    • Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): A prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention
    • W.W. O'Neill, and et al. Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention J. Am. Coll. Cardiol. 50 2007 397 405
    • (2007) J. Am. Coll. Cardiol. , vol.50 , pp. 397-405
    • O'Neill, W.W.1
  • 69
    • 73449127832 scopus 로고    scopus 로고
    • Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction
    • G.W. Stone, and et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction Circ. Cardiovasc. Interv. 2 2009 366 375
    • (2009) Circ. Cardiovasc. Interv. , vol.2 , pp. 366-375
    • Stone, G.W.1
  • 70
    • 84940957244 scopus 로고    scopus 로고
    • 'Optimized' delivery of intracoronary supersaturated oxygen in acute anterior myocardial infarction: A feasibility and safety study
    • Published online December 15, 2014
    • I.D. Hanson, and et al. 'Optimized' delivery of intracoronary supersaturated oxygen in acute anterior myocardial infarction: a feasibility and safety study Catheter. Cardiovasc. Interv. 2014 10.1002/ccd.25773 Published online December 15, 2014
    • (2014) Catheter. Cardiovasc. Interv.
    • Hanson, I.D.1
  • 71
    • 84896831150 scopus 로고    scopus 로고
    • DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial
    • R. Hofmann, and et al. DETermination of the role of OXygen in suspected Acute Myocardial Infarction trial Am. Heart J. 167 2014 322 328
    • (2014) Am. Heart J. , vol.167 , pp. 322-328
    • Hofmann, R.1
  • 72
    • 84863414961 scopus 로고    scopus 로고
    • A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen in myocarDial infarction study (AVOID Study)
    • D. Stub, and et al. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocarDial infarction study (AVOID Study) Am. Heart J. 163 2012 339 345
    • (2012) Am. Heart J. , vol.163 , pp. 339-345
    • Stub, D.1
  • 73
    • 84935510407 scopus 로고    scopus 로고
    • Air versus oxygen in ST-elevation myocardial infarction
    • D. Stub, and et al. Air versus oxygen in ST-elevation myocardial infarction Circulation 131 2015 2143 2450
    • (2015) Circulation , vol.131 , pp. 2143-2450
    • Stub, D.1
  • 74
    • 70349335996 scopus 로고    scopus 로고
    • Adenosine receptors and reperfusion injury of the heart
    • C.N. Wilson, S.J. Mustafa, Springer
    • J.P. Headrick, and R.D. Lasley Adenosine receptors and reperfusion injury of the heart C.N. Wilson, S.J. Mustafa, Adenosine Receptors in Health and Disease 2009 Springer 189 214
    • (2009) Adenosine Receptors in Health and Disease , pp. 189-214
    • Headrick, J.P.1    Lasley, R.D.2
  • 75
    • 33846891002 scopus 로고    scopus 로고
    • Role of adenosine as adjunctive therapy in acute myocardial infarction
    • M.B. Forman, and et al. Role of adenosine as adjunctive therapy in acute myocardial infarction Cardiovasc. Drug Rev. 24 2006 116 147
    • (2006) Cardiovasc. Drug Rev. , vol.24 , pp. 116-147
    • Forman, M.B.1
  • 76
    • 0034625177 scopus 로고    scopus 로고
    • Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
    • M. Marzilli, and et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
    • (2000) Circulation , vol.101 , pp. 2154-2159
    • Marzilli, M.1
  • 77
    • 79953719389 scopus 로고    scopus 로고
    • High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction
    • W. Desmet, and et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction Eur. Heart J. 32 2011 867 877
    • (2011) Eur. Heart J. , vol.32 , pp. 867-877
    • Desmet, W.1
  • 78
    • 77950899231 scopus 로고    scopus 로고
    • Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction a randomized controlled trial
    • M.L. Fokkema, and et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction a randomized controlled trial Circ. Cardiovasc. Interv. 2 2009 323 329
    • (2009) Circ. Cardiovasc. Interv. , vol.2 , pp. 323-329
    • Fokkema, M.L.1
  • 79
    • 84879411789 scopus 로고    scopus 로고
    • Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: The REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
    • G. Niccoli, and et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) JACC Cardiovasc. Interv. 6 2013 580 589
    • (2013) JACC Cardiovasc. Interv. , vol.6 , pp. 580-589
    • Niccoli, G.1
  • 80
    • 0033571512 scopus 로고    scopus 로고
    • Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial
    • K.W. Mahaffey, and et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial J. Am. Coll. Cardiol. 34 1999 1711 1720
    • (1999) J. Am. Coll. Cardiol. , vol.34 , pp. 1711-1720
    • Mahaffey, K.W.1
  • 81
    • 20344394410 scopus 로고    scopus 로고
    • A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)
    • A.M. Ross, and et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J. Am. Coll. Cardiol. 45 2005 1775 1780
    • (2005) J. Am. Coll. Cardiol. , vol.45 , pp. 1775-1780
    • Ross, A.M.1
  • 82
    • 84908140852 scopus 로고    scopus 로고
    • The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: Study protocol for a randomised controlled trial
    • S.A. Nazir, and et al. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial Trials 15 2014 371
    • (2014) Trials , vol.15 , pp. 371
    • Nazir, S.A.1
  • 83
    • 0026343631 scopus 로고
    • Intravenous nitroglycerin unloading in acute myocardial infarction
    • B.I. Jugdutt Intravenous nitroglycerin unloading in acute myocardial infarction Am. J. Cardiol. 68 1991 52d 63d
    • (1991) Am. J. Cardiol. , vol.68 , pp. 52d-63d
    • Jugdutt, B.I.1
  • 84
    • 0028957612 scopus 로고
    • Nitrates in myocardial infarction: Influence on infarct size, reperfusion, and ventricular remodelling
    • J.L. Morris, and et al. Nitrates in myocardial infarction: influence on infarct size, reperfusion, and ventricular remodelling Br. Heart J. 73 1995 310 319
    • (1995) Br. Heart J. , vol.73 , pp. 310-319
    • Morris, J.L.1
  • 85
    • 0028273258 scopus 로고    scopus 로고
    • Anonymous (1994) GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343, 1115-1122
    • Anonymous (1994) GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343, 1115-1122
  • 86
    • 84900872637 scopus 로고    scopus 로고
    • Intravenous sodium nitrite in acute ST-elevation myocardial infarction: A randomized controlled trial (NIAMI)
    • N. Siddiqi, and et al. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI) Eur. Heart J. 35 2014 1255 1262
    • (2014) Eur. Heart J. , vol.35 , pp. 1255-1262
    • Siddiqi, N.1
  • 88
    • 84877668953 scopus 로고    scopus 로고
    • The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): Study protocol of a randomised controlled trial
    • D.A. Jones, and et al. The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial BMJ Open 3 2013 e002813
    • (2013) BMJ Open , vol.3 , pp. e002813
    • Jones, D.A.1
  • 89
    • 27744496466 scopus 로고    scopus 로고
    • Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting
    • V. Tomic, and et al. Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting Circulation 112 2005 2912 2920
    • (2005) Circulation , vol.112 , pp. 2912-2920
    • Tomic, V.1
  • 90
    • 0030588970 scopus 로고    scopus 로고
    • Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project
    • R.H. Jones, and et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project J. Am. Coll. Cardiol. 28 1996 1478 1487
    • (1996) J. Am. Coll. Cardiol. , vol.28 , pp. 1478-1487
    • Jones, R.H.1
  • 91
    • 40749126460 scopus 로고    scopus 로고
    • Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: Results of the EXPEDITION study
    • R.M. Mentzer Jr, and et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study Ann. Thorac. Surg. 85 2008 1261 1270
    • (2008) Ann. Thorac. Surg. , vol.85 , pp. 1261-1270
    • Mentzer, R.M.1
  • 92
    • 80055033089 scopus 로고    scopus 로고
    • The therapeutic potential of ischemic conditioning: An update
    • D.J. Hausenloy, and D.M. Yellon The therapeutic potential of ischemic conditioning: an update Nat. Rev. Cardiol. 8 2011 619 629
    • (2011) Nat. Rev. Cardiol. , vol.8 , pp. 619-629
    • Hausenloy, D.J.1    Yellon, D.M.2
  • 93
    • 84920053359 scopus 로고    scopus 로고
    • Cardioprotection for percutaneous coronary intervention: Reperfusion quality as well as quantity
    • J.P. Giblett, and et al. Cardioprotection for percutaneous coronary intervention: reperfusion quality as well as quantity Int. J. Cardiol. 177 2014 786 793
    • (2014) Int. J. Cardiol. , vol.177 , pp. 786-793
    • Giblett, J.P.1
  • 94
    • 54949112815 scopus 로고    scopus 로고
    • Ischaemic preconditioning during cardiac surgery: Systematic review and meta-analysis of perioperative outcomes in randomised clinical trials
    • S.R. Walsh, and et al. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials Eur. J. Cardiothorac. Surg. 34 2008 985 994
    • (2008) Eur. J. Cardiothorac. Surg. , vol.34 , pp. 985-994
    • Walsh, S.R.1
  • 95
    • 77249107745 scopus 로고    scopus 로고
    • Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial
    • H.E. Botker, and et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
    • (2010) Lancet , vol.375 , pp. 727-734
    • Botker, H.E.1
  • 96
    • 84892761049 scopus 로고    scopus 로고
    • Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention
    • A.D. Sloth, and et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention Eur. Heart J. 35 2014 168 175
    • (2014) Eur. Heart J. , vol.35 , pp. 168-175
    • Sloth, A.D.1
  • 97
    • 74049108136 scopus 로고    scopus 로고
    • Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: Enhancement by opioid action
    • I. Rentoukas, and et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action JACC Cardiovasc. Interv. 3 2010 49 55
    • (2010) JACC Cardiovasc. Interv. , vol.3 , pp. 49-55
    • Rentoukas, I.1
  • 98
    • 84921342036 scopus 로고    scopus 로고
    • Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction
    • S.K. White, and et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction JACC Cardiovasc. Interv. 8 2014 178 188
    • (2014) JACC Cardiovasc. Interv. , vol.8 , pp. 178-188
    • White, S.K.1
  • 99
    • 84936821528 scopus 로고    scopus 로고
    • Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery: A multi-center double-blind randomized controlled clinical trial
    • Hausenloy, D.J. (2015) Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery: a multi-center double-blind randomized controlled clinical trial. In American College of Cardiology Scientific Sessions Abstract 408-16
    • (2015) American College of Cardiology Scientific Sessions Abstract , pp. 408-416
    • Hausenloy, D.J.1
  • 100
    • 83555172635 scopus 로고    scopus 로고
    • Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol: A clinical trial
    • E. Kottenberg, and et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol: a clinical trial Acta Anaesthesiol. Scand. 56 2012 30 38
    • (2012) Acta Anaesthesiol. Scand. , vol.56 , pp. 30-38
    • Kottenberg, E.1
  • 101
    • 84886016180 scopus 로고    scopus 로고
    • Ischemic postconditioning during primary percutaneous coronary intervention: The effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial
    • J.Y. Hahn, and et al. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial Circulation 128 2013 1889 1896
    • (2013) Circulation , vol.128 , pp. 1889-1896
    • Hahn, J.Y.1
  • 102
    • 84904707955 scopus 로고    scopus 로고
    • Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    • S. Limalanathan, and et al. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial J. Am. Heart Assoc. 3 2014 e000679
    • (2014) J. Am. Heart Assoc. , vol.3 , pp. e000679
    • Limalanathan, S.1
  • 103
    • 84941318740 scopus 로고    scopus 로고
    • Lack of benefit of ischemic postconditioning after routine thrombus aspiration during reperfusion: Immediate and midterm results
    • Published online March 27, 2015
    • A. Luz, and et al. Lack of benefit of ischemic postconditioning after routine thrombus aspiration during reperfusion: immediate and midterm results J. Cardiovasc. Pharmacol. Ther. 2015 10.1177/1074248415578171 Published online March 27, 2015
    • (2015) J. Cardiovasc. Pharmacol. Ther.
    • Luz, A.1
  • 104
    • 77957863131 scopus 로고    scopus 로고
    • Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis
    • P.R. Hansen, and et al. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis Int. J. Cardiol. 144 2010 22 25
    • (2010) Int. J. Cardiol. , vol.144 , pp. 22-25
    • Hansen, P.R.1
  • 105
    • 84922220217 scopus 로고    scopus 로고
    • Cardioprotective role of ischemic postconditioning in acute myocardial infarction: A systematic review and meta-analysis
    • A.R. Khan, and et al. Cardioprotective role of ischemic postconditioning in acute myocardial infarction: a systematic review and meta-analysis Am. Heart J. 168 2014 512 521
    • (2014) Am. Heart J. , vol.168 , pp. 512-521
    • Khan, A.R.1
  • 106
    • 40749130846 scopus 로고    scopus 로고
    • Long-term benefit of postconditioning
    • H. Thibault, and et al. Long-term benefit of postconditioning Circulation 117 2008 1037 1044
    • (2008) Circulation , vol.117 , pp. 1037-1044
    • Thibault, H.1
  • 107
    • 84883788486 scopus 로고    scopus 로고
    • Remote ischaemic postconditioning: Does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial
    • F. Carrasco-Chinchilla, and et al. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial Heart 99 2013 1431 1437
    • (2013) Heart , vol.99 , pp. 1431-1437
    • Carrasco-Chinchilla, F.1
  • 108
    • 84900408485 scopus 로고    scopus 로고
    • Remote ischemic postconditioning during percutaneous coronary interventions: Remote ischemic postconditioning-percutaneous coronary intervention randomized trial
    • S. Lavi, and et al. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial Circ. Cardiovasc. Interv. 7 2014 225 232
    • (2014) Circ. Cardiovasc. Interv. , vol.7 , pp. 225-232
    • Lavi, S.1
  • 109
    • 84905816451 scopus 로고    scopus 로고
    • Letter by Giblett and Hoole regarding article, 'Remote ischemic postconditioning during percutaneous coronary interventions: Remote ischemic postconditioning-percutaneous coronary intervention randomized trial'
    • J.P. Giblett, and S.P. Hoole Letter by Giblett and Hoole regarding article, 'Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial' Circ. Cardiovasc. Interv. 7 2014 422
    • (2014) Circ. Cardiovasc. Interv. , vol.7 , pp. 422
    • Giblett, J.P.1    Hoole, S.P.2
  • 110
    • 42549129618 scopus 로고    scopus 로고
    • Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size
    • M. Götberg, and et al. Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size BMC Cardiovasc. Dis. 8 2008 7
    • (2008) BMC Cardiovasc. Dis. , vol.8 , pp. 7
    • Götberg, M.1
  • 111
    • 0037021544 scopus 로고    scopus 로고
    • Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction
    • S.R. Dixon, and et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction J. Am. Coll. Cardiol. 40 2002 1928 1934
    • (2002) J. Am. Coll. Cardiol. , vol.40 , pp. 1928-1934
    • Dixon, S.R.1
  • 112
    • 84878320736 scopus 로고    scopus 로고
    • A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction
    • D. Erlinge, and et al. A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction Eurointervention 8 2013 1435 1440
    • (2013) Eurointervention , vol.8 , pp. 1435-1440
    • Erlinge, D.1
  • 113
    • 84899868947 scopus 로고    scopus 로고
    • Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction: The CHILL-MI Trial: A Randomized Controlled Study of the Use of Central Venous Catheter Core Cooling Combined with Cold Saline as an Adjunct to Percutaneous Coronary Intervention for the Treatment of Acute Myocardial Infarction
    • D. Erlinge, and et al. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction: The CHILL-MI Trial: A Randomized Controlled Study of the Use of Central Venous Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention for the Treatment of Acute Myocardial Infarction J. Am. Coll. Cardiol. 63 2014 1857 1865
    • (2014) J. Am. Coll. Cardiol. , vol.63 , pp. 1857-1865
    • Erlinge, D.1
  • 114
    • 84937580548 scopus 로고    scopus 로고
    • Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment-elevation myocardial infarction
    • G. Nichol, and et al. Prospective, multicenter, randomized, controlled pilot trial of peritoneal hypothermia in patients with ST-segment-elevation myocardial infarction Circ. Cardiovasc. Interv. 8 2015 e001965
    • (2015) Circ. Cardiovasc. Interv. , vol.8 , pp. e001965
    • Nichol, G.1
  • 115
    • 13444282326 scopus 로고    scopus 로고
    • Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury
    • L. Argaud, and et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury J. Mol. Cell. Cardiol. 38 2005 367 374
    • (2005) J. Mol. Cell. Cardiol. , vol.38 , pp. 367-374
    • Argaud, L.1
  • 116
    • 48249109117 scopus 로고    scopus 로고
    • Effect of cyclosporine on reperfusion injury in acute myocardial infarction
    • C. Piot, and et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N. Engl. J. Med. 359 2008 473 481
    • (2008) N. Engl. J. Med. , vol.359 , pp. 473-481
    • Piot, C.1
  • 117
    • 77952368170 scopus 로고    scopus 로고
    • TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition
    • S. Schaller, and et al. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition J. Pharmacol. Exp. Ther. 333 2010 696 706
    • (2010) J. Pharmacol. Exp. Ther. , vol.333 , pp. 696-706
    • Schaller, S.1
  • 118
    • 84893688780 scopus 로고    scopus 로고
    • Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase i trial
    • S. Le Lamer, and et al. Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial J. Transl. Med. 12 2014 38
    • (2014) J. Transl. Med. , vol.12 , pp. 38
    • Le Lamer, S.1
  • 119
    • 84924094035 scopus 로고    scopus 로고
    • Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results
    • D. Atar, and et al. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results Eur. Heart J. 36 2014 112 119
    • (2014) Eur. Heart J. , vol.36 , pp. 112-119
    • Atar, D.1
  • 120
    • 84925329275 scopus 로고    scopus 로고
    • Mitochondrial care in acute myocardial infarction
    • H.E. Botker Mitochondrial care in acute myocardial infarction Eur. Heart J. 36 2015 77 79
    • (2015) Eur. Heart J. , vol.36 , pp. 77-79
    • Botker, H.E.1
  • 121
    • 84875149020 scopus 로고    scopus 로고
    • Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide
    • R.A. Kloner, and et al. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide J. Am. Heart Assoc. 1 2012 e001644
    • (2012) J. Am. Heart Assoc. , vol.1 , pp. e001644
    • Kloner, R.A.1
  • 122
    • 84875422028 scopus 로고    scopus 로고
    • Rationale and design of the EMBRACE STEMI study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
    • A.K. Chakrabarti, and et al. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction Am. Heart J. 165 2013 509 514
    • (2013) Am. Heart J. , vol.165 , pp. 509-514
    • Chakrabarti, A.K.1
  • 123
    • 84963699245 scopus 로고    scopus 로고
    • A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction
    • Gibson, C.M. (2015) A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability, and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. In American College of Cardiology Scientific Sessions Abstract 402-10
    • (2015) American College of Cardiology Scientific Sessions Abstract , pp. 402-410
    • Gibson, C.M.1
  • 124
    • 35448998412 scopus 로고    scopus 로고
    • Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): Two randomised trials
    • M. Kitakaze, and et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials Lancet 370 2007 1483 1493
    • (2007) Lancet , vol.370 , pp. 1483-1493
    • Kitakaze, M.1
  • 125
    • 41649093421 scopus 로고    scopus 로고
    • Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat
    • N. Landa, and et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat Circulation 117 2008 1388 1396
    • (2008) Circulation , vol.117 , pp. 1388-1396
    • Landa, N.1
  • 126
    • 69249163009 scopus 로고    scopus 로고
    • Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine
    • J. Leor, and et al. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine J. Am. Coll. Cardiol. 54 2009 1014 1023
    • (2009) J. Am. Coll. Cardiol. , vol.54 , pp. 1014-1023
    • Leor, J.1
  • 127
    • 84925840655 scopus 로고    scopus 로고
    • Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: A first-in-man study
    • N. Frey, and et al. Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study Circ. Cardiovasc. Interv. 7 2014 806 812
    • (2014) Circ. Cardiovasc. Interv. , vol.7 , pp. 806-812
    • Frey, N.1
  • 128
    • 5644285411 scopus 로고    scopus 로고
    • P38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat
    • F. See, and et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat J. Am. Coll. Cardiol. 44 2004 1679 1689
    • (2004) J. Am. Coll. Cardiol. , vol.44 , pp. 1679-1689
    • See, F.1
  • 129
    • 0033528695 scopus 로고    scopus 로고
    • Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
    • X.L. Ma, and et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion Circulation 99 1999 1685 1691
    • (1999) Circulation , vol.99 , pp. 1685-1691
    • Ma, X.L.1
  • 130
    • 84908310935 scopus 로고    scopus 로고
    • Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: A randomised phase 2 trial
    • L.K. Newby, and et al. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial Lancet 384 2014 1187 1195
    • (2014) Lancet , vol.384 , pp. 1187-1195
    • Newby, L.K.1
  • 131
    • 16244367746 scopus 로고    scopus 로고
    • 15-42 protects the myocardium against ischemia-reperfusion injury
    • 15-42 protects the myocardium against ischemia-reperfusion injury Nat. Med. 11 2005 298 304
    • (2005) Nat. Med. , vol.11 , pp. 298-304
    • Petzelbauer, P.1
  • 132
    • 34250858254 scopus 로고    scopus 로고
    • The fibrin-derived peptide Bβ15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury
    • J.P. Roesner, and et al. The fibrin-derived peptide Bβ15-42 is cardioprotective in a pig model of myocardial ischemia-reperfusion injury Crit. Care Med. 35 2007 1730 1735
    • (2007) Crit. Care Med. , vol.35 , pp. 1730-1735
    • Roesner, J.P.1
  • 133
    • 60049083078 scopus 로고    scopus 로고
    • Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results of the FIRE (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) Trial
    • D. Atar, and et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results of the FIRE (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) Trial J. Am. Coll. Cardiol. 53 2009 720 729
    • (2009) J. Am. Coll. Cardiol. , vol.53 , pp. 720-729
    • Atar, D.1
  • 134
    • 84863560602 scopus 로고    scopus 로고
    • Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
    • J. Lonborg, and et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur. Heart J. 33 2012 1491 1499
    • (2012) Eur. Heart J. , vol.33 , pp. 1491-1499
    • Lonborg, J.1
  • 135
    • 84860807487 scopus 로고    scopus 로고
    • Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia
    • J. Lonborg, and et al. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia Circ. Cardiovasc. Interv. 5 2012 288 295
    • (2012) Circ. Cardiovasc. Interv. , vol.5 , pp. 288-295
    • Lonborg, J.1
  • 136
    • 79960792096 scopus 로고    scopus 로고
    • Effect of pretreatment with pioglitazone on reperfusion injury in diabetic patients with acute myocardial infarction
    • Y. Kataoka, and et al. Effect of pretreatment with pioglitazone on reperfusion injury in diabetic patients with acute myocardial infarction Circ. J. 75 2011 1968 1974
    • (2011) Circ. J. , vol.75 , pp. 1968-1974
    • Kataoka, Y.1
  • 137
    • 84898607351 scopus 로고    scopus 로고
    • Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: The GIPS-III randomized clinical trial
    • C.P. Lexis, and et al. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial JAMA 311 2014 1526 1535
    • (2014) JAMA , vol.311 , pp. 1526-1535
    • Lexis, C.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.